The government is examining Pfizer’s request for indemnity and will take a decision in the larger interest of people and on merit, NITI Aayog

Due to the unprecedented COVID-19 crisis in India, the global supply of COVAX has been badly hit, so much so that there are many

India has become the second country after the US to have crossed 20 crore cumulative COVID-19 vaccination coverage, the Union health ministry said on

A Lancet panel of experts on India on Wednesday proposed central systems for the procurement and distribution of free Covid vaccines, part of an

In the first of its kind study since the launch of AstraZeneca’s Covishield and Bharat Biotech’s Covaxin in the country, the Indian Council of

Bharat Biotech on Tuesday said it expects approval for its COVID-19 vaccine Covaxin from the World Health Organisation for Emergency Use Authorisation during July-September. The

More than 1.77 crore doses of anti-coronavirus vaccines are still available with the states and Union Territories, while seven lakh doses are in the

Moderna is expecting to launch a single-dose COVID-19 vaccine in India next year and is in talks with Cipla among other Indian firms, while

A steady decline in daily new COVID-19 cases has been observed since the last 17 days in India, the Union health ministry said on

Bharat Biotech International Limited (BBIL) has conveyed to the government that it has already submitted 90 per cent of documents to WHO for obtaining